Cargando…
CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
The impaired T cell responses observed in chronic hepatitis B (HBV) patients are considered to contribute to the chronicity of the infection. Research on this impairment has been focused on CD8(+) T cells because of their cytotoxic effector function; however, CD4(+) T cells are crucial in the proper...
Autores principales: | Buschow, Sonja I., Jansen, Diahann T. S. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148211/ https://www.ncbi.nlm.nih.gov/pubmed/34066322 http://dx.doi.org/10.3390/cells10051114 |
Ejemplares similares
-
Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures
por: Jansen, Diahann TSL, et al.
Publicado: (2021) -
Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo
por: Jansen, Diahann T. S. L., et al.
Publicado: (2023) -
Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength
por: de Beijer, Monique T. A., et al.
Publicado: (2020) -
The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function
por: van der Aa, Evelyn, et al.
Publicado: (2016) -
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
por: Bouzid, Rachid, et al.
Publicado: (2020)